These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas. Wong ML; Prawira A; Kaye AH; Hovens CM J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in malignant glioma--a target for antitumor therapy? Tuettenberg J; Friedel C; Vajkoczy P Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996 [TBL] [Abstract][Full Text] [Related]
5. [Anti-angiogenesis treatment for brain tumors: present and future]. Takano S; Matsumura A No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703 [No Abstract] [Full Text] [Related]
6. Antiangiogenesis: biology and utility in the treatment of gliomas. Chamberlain MC Expert Rev Neurother; 2008 Oct; 8(10):1419-23. PubMed ID: 18928336 [No Abstract] [Full Text] [Related]
7. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas. Argyriou AA; Giannopoulou E; Kalofonos HP Oncology; 2009; 77(1):1-11. PubMed ID: 19439998 [TBL] [Abstract][Full Text] [Related]
8. Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. Wu ZP; Gao CW; Wu YG; Zhu QS; Yan Chen ; Xin Liu ; Chuen Liu Integr Cancer Ther; 2009 Mar; 8(1):88-92. PubMed ID: 19174507 [TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic approaches to malignant gliomas. Soffietti R; Trevisan E; Bertero L; Bosa C; Ruda R Curr Cancer Drug Targets; 2012 Mar; 12(3):279-88. PubMed ID: 22229250 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and invasion in malignant gliomas. Chi A; Norden AD; Wen PY Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents. Perry JR Curr Opin Neurol; 2010 Dec; 23(6):592-6. PubMed ID: 20881488 [TBL] [Abstract][Full Text] [Related]
12. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy. Rege TA; Fears CY; Gladson CL Neuro Oncol; 2005 Apr; 7(2):106-21. PubMed ID: 15831230 [TBL] [Abstract][Full Text] [Related]
13. ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis. Anderson JC; Grammer JR; Wang W; Nabors LB; Henkin J; Stewart JE; Gladson CL Cancer Biol Ther; 2007 Mar; 6(3):454-62. PubMed ID: 17384534 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in glioma: molecular mechanisms and roadblocks to translation. Bögler O; Mikkelsen T Cancer J; 2003; 9(3):205-13. PubMed ID: 12952305 [TBL] [Abstract][Full Text] [Related]
18. New agents and new end points for recurrent gliomas. Brandes AA; Franceschi E J Clin Oncol; 2011 Mar; 29(9):e245-6; author reply e247. PubMed ID: 21282544 [No Abstract] [Full Text] [Related]
19. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823 [TBL] [Abstract][Full Text] [Related]